This is a call for people wanting to sign up for the "Structure-Based DrugEBIlity" webinar that will be hosted next Wednesday 4th April at 3.30pm (GMT).
It will be a 45 minute webinar where you will be taken through our DrugEBIlity interface.
The DrugEBIlity interface is a structure-based druggability search engine where users can survey different types of druggability scores of a given protein structure.
Remember to register your interest in our webinars on the Doodle Poll. Make sure that you leave your **email address** as well as your name so that we can send the connection details to you.
Any problems, please contact chembl-help@ebi.ac.uk.
(Generated with DALL-E 3 ∙ 30 October 2023 at 1:48 pm) We have some very exciting news to report: the new SureChEMBL is now available! Hooray! What is SureChEMBL, you may ask. Good question! In our portfolio of chemical biology services, alongside our established database of bioactivity data for drug-like molecules ChEMBL , our dictionary of annotated small molecule entities ChEBI , and our compound cross-referencing system UniChem , we also deliver a database of annotated patents! Almost 10 years ago , EMBL-EBI acquired the SureChem system of chemically annotated patents and made this freely accessible in the public domain as SureChEMBL. Since then, our team has continued to maintain and deliver SureChEMBL. However, this has become increasingly challenging due to the complexities of the underlying codebase. We were awarded a Wellcome Trust grant in 2021 to completely overhaul SureChEMBL, with a new UI, backend infrastructure, and new f
Comments